ACB
Price
$4.01
Change
-$0.28 (-6.53%)
Updated
Apr 4 closing price
Capitalization
238.86M
75 days until earnings call
CRDL
Price
$0.81
Change
-$0.10 (-10.99%)
Updated
Apr 4 closing price
Capitalization
124.33M
45 days until earnings call
Ad is loading...

ACB vs CRDL

Header iconACB vs CRDL Comparison
Open Charts ACB vs CRDLBanner chart's image
Aurora Cannabis
Price$4.01
Change-$0.28 (-6.53%)
Volume$1.02M
Capitalization238.86M
Cardiol Therapeutics
Price$0.81
Change-$0.10 (-10.99%)
Volume$228.06K
Capitalization124.33M
ACB vs CRDL Comparison Chart
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACB vs. CRDL commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Hold and CRDL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (ACB: $4.29 vs. CRDL: $0.91)
Brand notoriety: ACB: Notable vs. CRDL: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACB: 20% vs. CRDL: 84%
Market capitalization -- ACB: $238.86M vs. CRDL: $124.33M
ACB [@Pharmaceuticals: Other] is valued at $238.86M. CRDL’s [@Pharmaceuticals: Other] market capitalization is $124.33M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileCRDL’s FA Score has 0 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • CRDL’s FA Score: 0 green, 5 red.
According to our system of comparison, ACB is a better buy in the long-term than CRDL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 3 TA indicator(s) are bullish while CRDL’s TA Score has 4 bullish TA indicator(s).

  • ACB’s TA Score: 3 bullish, 5 bearish.
  • CRDL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CRDL is a better buy in the short-term than ACB.

Price Growth

ACB (@Pharmaceuticals: Other) experienced а -7.14% price change this week, while CRDL (@Pharmaceuticals: Other) price change was -8.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -4.71%. For the same industry, the average monthly price growth was -3.64%, and the average quarterly price growth was -11.61%.

Reported Earning Dates

ACB is expected to report earnings on Jun 19, 2025.

CRDL is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-4.71% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACB($239M) has a higher market cap than CRDL($124M). ACB YTD gains are higher at: 0.941 vs. CRDL (-28.906). CRDL has higher annual earnings (EBITDA): -30.61M vs. ACB (-1.64B). ACB has more cash in the bank: 149M vs. CRDL (40.5M). CRDL has less debt than ACB: CRDL (181K) vs ACB (103M). ACB has higher revenues than CRDL: ACB (212M) vs CRDL (0).
ACBCRDLACB / CRDL
Capitalization239M124M193%
EBITDA-1.64B-30.61M5,348%
Gain YTD0.941-28.906-3%
P/E RatioN/AN/A-
Revenue212M0-
Total Cash149M40.5M368%
Total Debt103M181K56,906%
FUNDAMENTALS RATINGS
ACB vs CRDL: Fundamental Ratings
ACB
CRDL
OUTLOOK RATING
1..100
7062
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
97
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9099
PRICE GROWTH RATING
1..100
7491
P/E GROWTH RATING
1..100
82100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACB's Valuation (56) in the Pharmaceuticals Other industry is somewhat better than the same rating for CRDL (97) in the null industry. This means that ACB’s stock grew somewhat faster than CRDL’s over the last 12 months.

ACB's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CRDL (100) in the null industry. This means that ACB’s stock grew similarly to CRDL’s over the last 12 months.

ACB's SMR Rating (90) in the Pharmaceuticals Other industry is in the same range as CRDL (99) in the null industry. This means that ACB’s stock grew similarly to CRDL’s over the last 12 months.

ACB's Price Growth Rating (74) in the Pharmaceuticals Other industry is in the same range as CRDL (91) in the null industry. This means that ACB’s stock grew similarly to CRDL’s over the last 12 months.

ACB's P/E Growth Rating (82) in the Pharmaceuticals Other industry is in the same range as CRDL (100) in the null industry. This means that ACB’s stock grew similarly to CRDL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBCRDL
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
77%
Bullish Trend 17 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRDL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PVETX16.87N/A
N/A
PACE Small/Medium Co Val Eq P2
CLIFX19.78N/A
N/A
Clifford Capital Partners Institutional
LVOSX17.81N/A
N/A
Lord Abbett Value Opportunities R4
TRWIX22.33N/A
N/A
Transamerica International Equity I2
FAMDX25.83N/A
N/A
FAM Small Cap Institutional

ACB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACB has been closely correlated with CGC. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if ACB jumps, then CGC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACB
1D Price
Change %
ACB100%
-4.03%
CGC - ACB
82%
Closely correlated
-9.78%
TLRY - ACB
73%
Closely correlated
-5.14%
SNDL - ACB
65%
Loosely correlated
-1.39%
CRON - ACB
64%
Loosely correlated
-1.66%
OGI - ACB
62%
Loosely correlated
-4.79%
More

CRDL and

Correlation & Price change

A.I.dvisor tells us that CRDL and DERM have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CRDL and DERM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDL
1D Price
Change %
CRDL100%
-1.27%
DERM - CRDL
27%
Poorly correlated
+5.61%
CGC - CRDL
27%
Poorly correlated
-9.78%
ACB - CRDL
26%
Poorly correlated
-4.03%
CRON - CRDL
26%
Poorly correlated
-1.66%
OGI - CRDL
26%
Poorly correlated
-4.79%
More